Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kezar Life Sciences
Kezar Life Sciences
Kezar to commence Phase IIa autoimmune hepatitis therapy trial
Clinical Trials Arena
Tue, 10/4/22 - 10:36 am
Kezar Life Sciences
clinical trials
zetomipzomib
autoimmune hepatitis
Amgen spinout Kezar hits PhII hurdle, all eyes on June readout for drug’s other study
Endpoints
Wed, 05/4/22 - 10:39 am
Amgen
Kezar Life Sciences
zetomipzomib
autoimmune disease
dermatomyositis
polymyositis
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours
Xconomy
Thu, 06/21/18 - 12:04 pm
biotech
IPOs
Eidos Therapeutics
Avrobio
XERIS
Aptinyx
Kezar Life Sciences
Magenta Therapeutics
